Solventum Corp.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.21B | $2.01B | $2.00B | $2.10B | $2.16B | $2.07B | $2.08B | $2.08B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | $1.29B | $1.10B | $1.03B | $1.14B | $1.18B | $1.11B | $1.12B | $1.17B |
| Gross Margin | 58.2% | 54.7% | 51.4% | 54.2% | 54.4% | 53.8% | 53.9% | 56.0% |
| Operating Expenses | ||||||||
| Research & Development | $178.0M | $189.0M | $174.0M | $183.0M | $189.0M | $193.0M | $199.0M | $189.0M |
| SG&A Expense | $927.0M | $827.0M | $759.0M | $780.0M | $772.0M | $769.0M | $784.0M | $701.0M |
| Operating Income | $181.0M | $81.0M | $125.0M | $1.69B | $214.0M | $152.0M | $136.0M | $275.0M |
| Operating Margin | 8.2% | 4.0% | 6.3% | 80.6% | 9.9% | 7.3% | 6.6% | 13.2% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $108.0M | $16.0M | $58.0M | $1.51B | $103.0M | $38.0M | $13.0M | $167.0M |
| Income Tax Expense | $15.0M | $3.0M | $-5.0M | $248.0M | $13.0M | $-99.0M | $-17.0M | $45.0M |
| Net Income | $92.0M | $13.0M | $63.0M | $1.27B | $90.0M | $137.0M | $31.0M | $122.0M |
| Net Margin | 4.2% | 0.6% | 3.2% | 60.4% | 4.2% | 6.6% | 1.5% | 5.9% |
| EPS (Basic) | $0.53 | $0.07 | $0.37 | $7.26 | $0.52 | $0.79 | $0.19 | $0.70 |
| EPS (Diluted) | $0.53 | $0.07 | $0.37 | $7.22 | $0.51 | $0.78 | $0.18 | $0.70 |
| Shares Outstanding (Basic) | 172.7M | 174.2M | 174.1M | 174.3M | 174.1M | 173.7M | 173.2M | 173.4M |
| Shares Outstanding (Diluted) | 173.3M | 175.5M | 175.3M | 175.4M | 175.2M | 174.8M | 173.7M | 173.9M |
| Dividends Per Share | — | — | — | — | — | — | — | — |